3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Stage IIIB Cervical Cancer: new trials by email Literature Review of Stage IIIB Cervical Cancer trials Research Report on Stage IIIB Cervical Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer eribulin mesylate - Recurrent Cervical Cancer, Stage IIIA Cervical Cancer | Phase 2 | Completed | University of Southern California | 32 | 2012-08-09 | 2025-11-06 |
| Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer behavioral, psychological or informational intervention - Ovarian Sarcoma, Ovarian Stromal Cancer | Phase 2 | Completed | Ohio State University Comprehensive Cancer Center | 100 | 2010-10-01 | 2018-05-30 |
| Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery Temsirolimus, Laboratory Biomarker Analysis - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 38 | 2009-12-01 | 2015-09-10 |
Uterine Cervical Neoplasms (3) · Breast Neoplasms (1) · Carcinoma, Ovarian Epithelial (1) · Endometrial Neoplasms (1) · Fallopian Tube Neoplasms (1) · Gestational Trophoblastic Disease (1) · Neoplasms (1) · Vaginal Neoplasms (1) · Vulvar Neoplasms (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Neoplasms by Site (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Uterine Cervical Diseases (3) · Uterine Diseases (3) · Uterine Neoplasms (3) · Neoplasms (2) · Adnexal Diseases (1) · Breast Diseases (1) · Carcinoma (1)
eribulin (1) · temsirolimus (1)
National Cancer Institute (NCI) (1) · Ohio State University Comprehensive Cancer Center (1) · University of Southern California (1)
United States (2) · Canada (1)
Anna Tinker (1) · Kristen M. Carpenter, Ph.D (1) · Lynda Roman, MD (1)
R21CA149675 (1)